REFERENCES:
1. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A report of the American college of Cardiology/American heart association task force on practice guidelines and the heart rhythm society. J Am Coll Cardiol . 2014;64(21):e1-e76. doi:10.1016/j.jacc.2014.03.022
2. Patel NJ, Deshmukh A, Pant S, et al. Contemporary trends of hospitalization for atrial fibrillation in the united states, 2000 through 2010 implications for healthcare planning. Circulation . 2014;129(23):2371-2379. doi:10.1161/CIRCULATIONAHA.114.008201
3. Mehra N, Kowlgi GN, Deshmukh AJ. Predictors of Outcomes in Patients with Atrial Fibrillation: What Can Be Used Now and What Hope Is in the Future. Curr Cardiovasc Risk Rep . 2020;14(9):1-14. doi:10.1007/s12170-020-00645-5
4. Arora S, Jaswaney R, Jani C, et al. Catheter Ablation for Atrial Fibrillation in Patients With Concurrent Heart Failure. Am J Cardiol . 2020;137:45-54. doi:10.1016/J.AMJCARD.2020.09.035
5. Packer DL, Mark DB, Robb RA, et al. Effect of Catheter Ablation vs Antiarrhythmic Drug Therapy on Mortality, Stroke, Bleeding, and Cardiac Arrest among Patients with Atrial Fibrillation: The CABANA Randomized Clinical Trial. In: JAMA - Journal of the American Medical Association . Vol 321. American Medical Association; 2019:1261-1274. doi:10.1001/jama.2019.0693
6. Kowlgi GN, Kapa S. Advances in Atrial Fibrillation Ablation: Energy Sources Here to Stay. Card Electrophysiol Clin . 2020;12(2):167-174. doi:10.1016/j.ccep.2020.02.005
7. Noseworthy PA, Gersh BJ, Kent DM, et al. Atrial fibrillation ablation in practice: assessing CABANA generalizability. Eur Heart J . 2019;40(16):1257-1264. doi:10.1093/EURHEARTJ/EHZ085
8. Noheria A, Kumar A, Wylie J V., Josephson ME. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch Intern Med . 2008;168(6):581-586. doi:10.1001/ARCHINTE.168.6.581
9. Pappone C, Vicedomini G, Augello G, et al. Radiofrequency catheter ablation and antiarrhythmic drug therapy: a prospective, randomized, 4-year follow-up trial: the APAF study. Circ Arrhythm Electrophysiol . 2011;4(6):808-814. doi:10.1161/CIRCEP.111.966408
10. Lau D, Sandhu RK, Andrade JG, Ezekowitz J, So H, Klarenbach S. Cost-utility of catheter ablation for atrial fibrillation in patients with heart failure: An economic evaluation. J Am Heart Assoc . 2021;10(14):19599. doi:10.1161/JAHA.120.019599
11. Chew DS, Loring Z, Anand J, et al. Economic Evaluation of Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure with Reduced Ejection Fraction. Circ Cardiovasc Qual Outcomes . Published online 2020:981-990. doi:10.1161/CIRCOUTCOMES.120.007094
12. Kowlgi GN, Gunda S, Padala SK, Koneru JN, Deshmukh AJ, Ellenbogen KA. Comparison of Frequency of Atrial Fibrillation in Blacks Versus Whites and the Utilization of Race in a Novel Risk Score. Am J Cardiol . 2020;135:68-76. doi:10.1016/j.amjcard.2020.08.029